Cargando…
Erythropoietin Interacts with Specific S100 Proteins
Erythropoietin (EPO) is a clinically significant four-helical cytokine, exhibiting erythropoietic, cytoprotective, immunomodulatory, and cancer-promoting activities. Despite vast knowledge on its signaling pathways and physiological effects, extracellular factors regulating EPO activity remain under...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773746/ https://www.ncbi.nlm.nih.gov/pubmed/35053268 http://dx.doi.org/10.3390/biom12010120 |
_version_ | 1784636170792075264 |
---|---|
author | Kazakov, Alexey S. Deryusheva, Evgenia I. Sokolov, Andrey S. Permyakova, Maria E. Litus, Ekaterina A. Rastrygina, Victoria A. Uversky, Vladimir N. Permyakov, Eugene A. Permyakov, Sergei E. |
author_facet | Kazakov, Alexey S. Deryusheva, Evgenia I. Sokolov, Andrey S. Permyakova, Maria E. Litus, Ekaterina A. Rastrygina, Victoria A. Uversky, Vladimir N. Permyakov, Eugene A. Permyakov, Sergei E. |
author_sort | Kazakov, Alexey S. |
collection | PubMed |
description | Erythropoietin (EPO) is a clinically significant four-helical cytokine, exhibiting erythropoietic, cytoprotective, immunomodulatory, and cancer-promoting activities. Despite vast knowledge on its signaling pathways and physiological effects, extracellular factors regulating EPO activity remain underexplored. Here we show by surface plasmon resonance spectroscopy, that among eighteen members of Ca(2+)-binding proteins of the S100 protein family studied, only S100A2, S100A6 and S100P proteins specifically recognize EPO with equilibrium dissociation constants ranging from 81 nM to 0.5 µM. The interactions occur exclusively under calcium excess. Bioinformatics analysis showed that the EPO-S100 interactions could be relevant to progression of neoplastic diseases, including cancer, and other diseases. The detailed knowledge of distinct physiological effects of the EPO-S100 interactions could favor development of more efficient clinical implications of EPO. Summing up our data with previous findings, we conclude that S100 proteins are potentially able to directly affect functional activities of specific members of all families of four-helical cytokines, and cytokines of other structural superfamilies. |
format | Online Article Text |
id | pubmed-8773746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87737462022-01-21 Erythropoietin Interacts with Specific S100 Proteins Kazakov, Alexey S. Deryusheva, Evgenia I. Sokolov, Andrey S. Permyakova, Maria E. Litus, Ekaterina A. Rastrygina, Victoria A. Uversky, Vladimir N. Permyakov, Eugene A. Permyakov, Sergei E. Biomolecules Article Erythropoietin (EPO) is a clinically significant four-helical cytokine, exhibiting erythropoietic, cytoprotective, immunomodulatory, and cancer-promoting activities. Despite vast knowledge on its signaling pathways and physiological effects, extracellular factors regulating EPO activity remain underexplored. Here we show by surface plasmon resonance spectroscopy, that among eighteen members of Ca(2+)-binding proteins of the S100 protein family studied, only S100A2, S100A6 and S100P proteins specifically recognize EPO with equilibrium dissociation constants ranging from 81 nM to 0.5 µM. The interactions occur exclusively under calcium excess. Bioinformatics analysis showed that the EPO-S100 interactions could be relevant to progression of neoplastic diseases, including cancer, and other diseases. The detailed knowledge of distinct physiological effects of the EPO-S100 interactions could favor development of more efficient clinical implications of EPO. Summing up our data with previous findings, we conclude that S100 proteins are potentially able to directly affect functional activities of specific members of all families of four-helical cytokines, and cytokines of other structural superfamilies. MDPI 2022-01-12 /pmc/articles/PMC8773746/ /pubmed/35053268 http://dx.doi.org/10.3390/biom12010120 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kazakov, Alexey S. Deryusheva, Evgenia I. Sokolov, Andrey S. Permyakova, Maria E. Litus, Ekaterina A. Rastrygina, Victoria A. Uversky, Vladimir N. Permyakov, Eugene A. Permyakov, Sergei E. Erythropoietin Interacts with Specific S100 Proteins |
title | Erythropoietin Interacts with Specific S100 Proteins |
title_full | Erythropoietin Interacts with Specific S100 Proteins |
title_fullStr | Erythropoietin Interacts with Specific S100 Proteins |
title_full_unstemmed | Erythropoietin Interacts with Specific S100 Proteins |
title_short | Erythropoietin Interacts with Specific S100 Proteins |
title_sort | erythropoietin interacts with specific s100 proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773746/ https://www.ncbi.nlm.nih.gov/pubmed/35053268 http://dx.doi.org/10.3390/biom12010120 |
work_keys_str_mv | AT kazakovalexeys erythropoietininteractswithspecifics100proteins AT deryushevaevgeniai erythropoietininteractswithspecifics100proteins AT sokolovandreys erythropoietininteractswithspecifics100proteins AT permyakovamariae erythropoietininteractswithspecifics100proteins AT litusekaterinaa erythropoietininteractswithspecifics100proteins AT rastryginavictoriaa erythropoietininteractswithspecifics100proteins AT uverskyvladimirn erythropoietininteractswithspecifics100proteins AT permyakoveugenea erythropoietininteractswithspecifics100proteins AT permyakovsergeie erythropoietininteractswithspecifics100proteins |